Cullinan Therapeutics, Inc. CGEM · Insights

website

109

Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for auto...

Price11.73

Market Cap720.9 M

Float48.2 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro